reports
Journey Medical Corporation to Participate in the Alliance Global Part...
Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase SCOTTSDALE, Ariz., May 15, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, announced today that Claude Maraoui, Co-Founder, President and Chief Executive Officer, will participate in ...
Mereo BioPharma Reports First Quarter 2024 Financial Results and Provi...
Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update LONDON, May 15, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced its financial results for the first quarter ended March 31, 2024, and provided an update on recent corporate highlights. The Company reported cash and cash equivalents of $48.7 million as of March 31, 2024 and continues to expect this to fund its operations into 2026. “2024 is off to an exciting start follo...
Galapagos and Blood Centers of America announce strategic collaboratio...
Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S. BCA's national network of blood centers will provide decentralized manufacturing services for Galapagos' CAR-T product candidates, close to cancer treatment centersCollaboration enables rapid deployment of Galapagos' decentralized CAR-T platform across the U.S., improving patient access to potentially life-saving CAR-T treatmentsImportant milestone for Galapagos' U.S. expansion strategy, supporting upcoming pivotal trials and potential future...
Galapagos en Blood Centers of America kondigen een strategische samenw...
Galapagos en Blood Centers of America kondigen een strategische samenwerking aan om Galapagos' gedecentraliseerde CAR-T productienetwerk in de VS versneld op te schalen BCA's nationale netwerk van bloedcentra zal gedecentraliseerde productiediensten leveren voor Galapagos’ CAR-T productkandidaten, dichtbij centra voor kankerbehandelingenDe samenwerking maakt snelle inzet van Galapagos' gedecentraliseerde CAR-T-platform in de VS mogelijk, waardoor de toegang tot potentieel levensreddende CAR-T-behandelingen voor patiënten verbetertBelangrijke mijlpaal voor Galapagos' expansiestrategie in de ...
Cidara Therapeutics Regains Compliance with Nasdaq Continued Listing R...
Cidara Therapeutics Regains Compliance with Nasdaq Continued Listing Rules SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced that on May 14, 2024 it received a letter from the Listing Qualifications Department staff (the Staff) of the Nasdaq Stock Market LLC (Nasdaq) notifying the Company that it has regained compliance with Nasd...
Celcuity Inc. Reports First Quarter Financial Results and Provides Cor...
Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update The Phase 3 VIKTORIA-1 trial remains on track to report topline data from PIK3CA wild type patient sub-group in the second half of 2024First patient dosed in a Phase 1b/2 clinical trial evaluating gedatolisib in combination with darolutamide in patients with metastatic castration resistant prostate cancer $177.7 million in cash, cash equivalents and short-term investments expected to provide runway into the first half of 2026 Management to host webcast and conference call today, May 15, 2024, at 4:30 p.m. E...
Five Below, Inc. Announces First Quarter Fiscal 2024 Earnings Release ...
Five Below, Inc. Announces First Quarter Fiscal 2024 Earnings Release and Conference Call Date PHILADELPHIA, PA, May 15, 2024 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ: FIVE), the trend-right, high-quality, extreme-value retailer for tweens, teens and beyond, today announced that its financial results for the first quarter of fiscal 2024 will be released after market close on Wednesday, June 5, 2024. The company will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results. Investors and analysts interested in participating in the call are invited to dial 412-...
IZEA Reports Q1 2024 Revenue of $7.0 million
IZEA Reports Q1 2024 Revenue of $7.0 million ORLANDO, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ), the premier provider of influencer marketing technology, data, and services for the Creator Economy, reported its financial and operational results for the first quarter ended March 31, 2024. Q1 2024 Financial Summary Compared to Q1 2023 Total revenue decreased 20.4% to $7.0 million, compared to $8.7 millionManaged Services revenue decreased 21.2% to $6.7 million, compared to $8.5 millionSaaS Services revenue increased 9.1% to $0.3 million, compared to $0.2 millionTotal costs an...
Kineta Reports First Quarter 2024 Financial Results and Provides Updat...
Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial and Corporate Activities Partial response and stable disease reported in combination cohort, and durable stable disease observed in monotherapy cohorts Favorable clinical safety and tolerability profile observed with no dose limiting toxicities and no evidence of CRS-associated cytokines observed at any dose level Cleared fifth of six monotherapy cohorts and second of four combination cohorts Kineta is actively exploring strategic alternatives to maximize value for al...
Apogee Announces Dosing of First Patient in Phase 2 Atopic Dermatitis ...
Apogee Announces Dosing of First Patient in Phase 2 Atopic Dermatitis Trial of APG777, a Novel Subcutaneous Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases Interim clinical data from APG777 Phase 1 healthy volunteers study exceeded all trial objectives and achieved a half-life of approximately 75 days with a potentially best-in-class profile 16-week proof-of-concept data from Part A of the Phase 2 trial expected in 2H 2025 Pipeline-in-a-product potential with a Phase 2 in asthma expected to initiate in 2025 and plans for additi...
Eyenovia Reports First Quarter 2024 Financial Results and Provides Upd...
Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III Program and its Two FDA Approved Commercial Products, Mydcombi and Clobetasol Remains on track towards accelerating development of its late-stage product candidate in the multi-billion-dollar pediatric progressive myopia market, MicroPine Preparing for a 3Q 2024 launch of the first new ophthalmic steroid in 15 years, clobetasol propionate ophthalmic suspension 0.05%, for the treatment of inflammation and pain following ocular surgery Company to host conference call and webcast today, May 15t...
CSX Executive Vice President and Chief Financial Officer to Address Wo...
CSX Executive Vice President and Chief Financial Officer to Address Wolfe Research Global Transportation & Industrials Conference JACKSONVILLE, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) Executive Vice President and Chief Financial Officer, Sean Pelkey, will address the 17th Annual Wolfe Research Global Transportation & Industrials Conference in New York on Wednesday, May 22, at 8:35 a.m. Eastern time. This address will be broadcast live via webcast at . A replay will be available following the conclusion of this event. This announcement, as well as additional financi...
United Fire Group, Inc. Declares a Common Stock Quarterly Cash Dividen...
United Fire Group, Inc. Declares a Common Stock Quarterly Cash Dividend of $0.16 per Share CEDAR RAPIDS, IOWA , May 15, 2024 (GLOBE NEWSWIRE) -- Today, the Board of Directors of United Fire Group, Inc. (Nasdaq: UFCS) ("UFG") declared a common stock quarterly cash dividend of $0.16 per share. This dividend will be payable June 14, 2024 to shareholders of record as of May 31, 2024. UFG has a long history of paying quarterly dividends, with the quarterly cash dividend declared today marking the 225th consecutive quarterly dividend paid, dating back to March 1968. About UFG Founded i...
Xometry Appoints Subir Dutt As Chief Sales Officer
Xometry Appoints Subir Dutt As Chief Sales Officer Brings Extensive Enterprise Sales Experience With Leadership Positions At Google, Oracle and CapGeminiExpert In AI, Cloud Services And Transformational Technologies To Help Clients Accelerate Their Digital JourneysSucceeds Kathy Mayerhofer, Who Will Work With Dutt To Ensure A Seamless Transition NORTH BETHESDA, Md., May 15, 2024 (GLOBE NEWSWIRE) -- Xometry, the global that connects buyers with suppliers of custom manufacturing services, today announced the appointment of Subir Dutt as the company’s new Chief Sales Officer. A widely...
Monte Rosa Therapeutics Announces Proposed Public Offering of Common S...
Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants BOSTON, May 15, 2024 (GLOBE NEWSWIRE) -- (“Monte Rosa”) (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that it has commenced an underwritten public offering of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of common stock. All of the shares of common stock and pre-funded warrants to purchase shares of common stock in the proposed offering are t...
Q.E.P. Co., Inc. Announces Special Cash Dividend of $1.00 per Share
Q.E.P. Co., Inc. Announces Special Cash Dividend of $1.00 per Share BOCA RATON, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- Q.E.P. CO., INC. (OTCQX: QEPC) (the “Company” or “QEP”) today announced that the Board of Directors of the Company has declared a special cash dividend of $1.00 per share on its common stock. The dividend will be payable on or about June 26, 2024 to stockholders of record as of the close of business on May 31, 2024. After payment of this dividend, the Company will continue to have sufficient working capital to make investments in the business and meet its operating needs ...
MYR Group Inc. to Participate in Sidoti Small Cap Investor Conference ...
MYR Group Inc. to Participate in Sidoti Small Cap Investor Conference in June THORNTON, Colo., May 15, 2024 (GLOBE NEWSWIRE) -- MYR Group Inc. (“MYR Group”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, commercial and industrial construction markets in the United States and Canada, announced it will participate in the 2024 Sidoti Small Cap Conference. MYR Group’s Chief Executive Officer, Rick Swartz, and Chief Financial Officer, Kelly Huntington, will meet virtually with institutional investors during the Sidoti Small Cap i...
Yield10 Bioscience Announces First Quarter 2024 Financial Results
Yield10 Bioscience Announces First Quarter 2024 Financial Results -Earns $1 million in milestone payments from Vision Bioenergy Oilseeds WOBURN, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today reported financial results for the first quarter ended March 31, 2024. "In the first quarter of 2024, we made the strategic decision to focus our resources on the commercialization of Camelina products targeting the aquafeed and nutritional markets for omega-3 fatty acids," said Oliver Peoples, ...
ScottsMiracle-Gro to Webcast Presentation at the William Blair 44th An...
ScottsMiracle-Gro to Webcast Presentation at the William Blair 44th Annual Growth Conference on June 6, 2024 MARYSVILLE, Ohio, May 15, 2024 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), the world’s leading marketer of branded consumer lawn and garden as well as indoor and hydroponic growing products, will participate in the William Blair 44th Annual Growth Conference in Chicago on Thursday, June 6, 2024. Matt Garth, Chief Financial and Administrative Officer, will be a featured speaker at the conference presenting a business update at approximately 8:00 CT. Investors an...
Old National Bancorp Announces Quarterly Dividends
Old National Bancorp Announces Quarterly Dividends EVANSVILLE, Ind., May 15, 2024 (GLOBE NEWSWIRE) -- Old National Bancorp (the “Company” or “Old National”) (NASDAQ: ONB) today announced that its Board of Directors declared a quarterly cash dividend of $0.14 per share on the Company’s outstanding shares of common stock. This quarterly cash dividend will be payable on June 17, 2024, to shareholders of record as of the close of business on June 5, 2024. In addition, the Board of Directors declared a quarterly cash dividend of $17.50 per share (equivalent to $0.4375 per depositary share or ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.